BLIS Technologies
View all Current opportunities
BLIS Technologies develops, manufactures and sells advanced
probiotics.
Their flagship strain of advanced probiotics BLIS K12™ has been
clinically shown to promote the body's natural defense against
Strep sore throat, prevent halitosis, and boost the immune
system.
In addition to developing a range of BLIS K12™ consumer
products, BLIS Technologies can also supply BLIS K12™ as an
ingredient.
BLIS Technologies is focused on the commercial development of
beneficial bacteria, which promote human health and have the added
advantage of producing the anti-bacterial substance called BLIS
(Bacteriocin-Like Inhibitory Substance).
In addition to their in-house test and research capabilities,
and links to a network of leading research institutes around the
world in the fields of probiotics and natural anti-microbial
molecules, the key to BLIS Technologies' innovation is their highly
experienced team of scientists.
Website: http://www.blis.co.nz/
The company profiled is one of the investment
opportunities currently available in New Zealand. Please note that
these opportunities are not endorsed or recommended by New Zealand
Trade and Enterprise (NZTE) and may be updated from time to time.
Investors are advised to contact our New Zealand-based Investment
Specialist to discuss further and to conduct their own due
diligence and independent advice on the relevant investment, before
committing to any investment.
